N4 Pharma (N4P)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 3.05p
   
  • Change Today:
      0.000p
  • 52 Week High: 3.05
  • 52 Week Low: 0.43
  • Currency: UK Pounds
  • Shares Issued: 101.46m
  • Volume: 64,699
  • Market Cap: 3.09m
2016-10-17 - Suspension of Listing

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -2028.6% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 44.2 n/a
Pr/Book 3.5  
Latest F'cast
Revenue -36.4% -100.0%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

N4 Pharma Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-14 n/a (0.01) (0.86)p n/a n/a n/a n/a 0.0%
31-Dec-15 n/a (0.16) (9.08)p n/a n/a n/a n/a 0.0%
31-Dec-16 n/a (0.19) (8.00)p n/a n/a n/a n/a 0.0%
31-Dec-17 0.11 (1.93) (1.26)p n/a n/a n/a n/a 0.0%
31-Dec-18 0.07 (1.39) (1.32)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

N4 Pharma Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 n/a n/a n/a n/a n/a n/a n/a 0.0%
31-Dec-20 n/a n/a n/a n/a n/a n/a n/a 0.0%

Copyright © 2019 FactSet Research Systems Inc. All rights reserved.

N4 Pharma Company Announcements

Interim Results 18-Sep-2019 07:00 RNS
Results of University of Queensland Study 20-Aug-2019 07:00 RNS
Holding(s) in Company 13-Aug-2019 11:16 RNS

Latest N4 Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

N4 Pharma Market Data

Currency UK Pounds
Share Price 3.05p
Change Today 0.000p
% Change 0.00 %
52 Week High 3.05
52 Week Low 0.43
Volume 64,699
Shares Issued 101.46m
Market Cap 3.09m

N4 Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
36.69% below the market average36.69% below the market average36.69% below the market average36.69% below the market average36.69% below the market average
65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average
Value
36.69% below the market average36.69% below the market average36.69% below the market average36.69% below the market average36.69% below the market average
65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average
Income Not Available
Growth
24.8% below the market average24.8% below the market average24.8% below the market average24.8% below the market average24.8% below the market average
24.32% below the sector average24.32% below the sector average24.32% below the sector average24.32% below the sector average24.32% below the sector average

N4 Pharma Dividends

No dividends found

Trades for 12-Nov-2019

Time Volume / Share Price
16:22 64,699 @ 2.95p

N4 Pharma Key Personnel

CEO Nigel Theobald

Top of Page